Should Patients With Acute Minor Ischemic Stroke With Isolated Internal Carotid Artery Occlusion Be Thrombolysed?


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
11 2022
Historique:
pubmed: 9 9 2022
medline: 27 10 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

We recently reported a worrying 30% rate of early neurological deterioration (END) occurring within 24 hours following intravenous thrombolysis (IVT) in minor stroke with isolated internal carotid artery occlusion (ie, without additional intracranial occlusion), mainly due to artery-to-artery embolism. Here, we hypothesize that in this setting IVT-as compared to no-IVT-may foster END, in particular by favoring artery-to-artery embolism from thrombus fragmentation. From a large multicenter retrospective database, we compared minor stroke (National Institutes of Health Stroke Scale score <6) isolated internal carotid artery occlusion patients treated within 4.5 hours of symptoms onset with either IVT or antithrombotic therapy between 2006 and 2020 (inclusion date varied among centers). Primary outcome was END within 24 hours (≥4 National Institutes of Health Stroke Scale points increase within 24 hours), and secondary outcomes were END within 7 days (END Overall, 189 patients were included (IVT=95; antithrombotics=94 [antiplatelets, n=58, anticoagulants, n=36]) from 34 centers. END within 24 hours and END In our population of minor strokes with iICAO, although END rate at 7 days and 3-month outcome were similar between the 2 groups, END-particularly END due to artery-to-artery embolism-occurred earlier following IVT. Prospective studies are warranted to further clarify the benefit/risk profile of IVT in this population.

Sections du résumé

BACKGROUND
We recently reported a worrying 30% rate of early neurological deterioration (END) occurring within 24 hours following intravenous thrombolysis (IVT) in minor stroke with isolated internal carotid artery occlusion (ie, without additional intracranial occlusion), mainly due to artery-to-artery embolism. Here, we hypothesize that in this setting IVT-as compared to no-IVT-may foster END, in particular by favoring artery-to-artery embolism from thrombus fragmentation.
METHODS
From a large multicenter retrospective database, we compared minor stroke (National Institutes of Health Stroke Scale score <6) isolated internal carotid artery occlusion patients treated within 4.5 hours of symptoms onset with either IVT or antithrombotic therapy between 2006 and 2020 (inclusion date varied among centers). Primary outcome was END within 24 hours (≥4 National Institutes of Health Stroke Scale points increase within 24 hours), and secondary outcomes were END within 7 days (END
RESULTS
Overall, 189 patients were included (IVT=95; antithrombotics=94 [antiplatelets, n=58, anticoagulants, n=36]) from 34 centers. END within 24 hours and END
CONCLUSIONS
In our population of minor strokes with iICAO, although END rate at 7 days and 3-month outcome were similar between the 2 groups, END-particularly END due to artery-to-artery embolism-occurred earlier following IVT. Prospective studies are warranted to further clarify the benefit/risk profile of IVT in this population.

Identifiants

pubmed: 36073368
doi: 10.1161/STROKEAHA.122.039228
doi:

Substances chimiques

Fibrinolytic Agents 0
Anticoagulants 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3304-3312

Investigateurs

Wagih Ben Hassen (W)
Bertrand Lapergue (B)
Ludovic Lucas (L)
Didier Leys (D)
Frédéric Philippeau (F)
Omar Bennani (O)
Laura Mechtouff (L)
Frédéric Klapczynski (F)
Olivier Detante (O)
Vincent Costalat (V)
Gioia Mione (G)
Sébastien Gazzola (S)
Séverine Debiais (S)
Serkan Cakmak (S)
Valer Grigoras (V)
Christian Denier (C)
Didier Smadja (D)
François Mounier-Vehier (F)
Roxane Peres (R)
Laurent Spelle (L)
Nicolas Bricout (N)
Serge Bracard (S)
Aude Triquenot (A)
Aïcha Lyoubi (A)
Jean-Philippe Cottier (JP)
Duc-Long Duong (DL)
Camille Ollivier (C)

Auteurs

Naouel Boulenoir (N)

Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France (N.B., M.O., L.B., P.S.).
Neurology Department, GHU Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Université de Paris, INSERM UMR 1266, FHU NeuroVasc, France (N.B., G.T., J.-C.B.).

Guillaume Turc (G)

Neurology Department, GHU Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Université de Paris, INSERM UMR 1266, FHU NeuroVasc, France (N.B., G.T., J.-C.B.).

Adrien Ter Schiphorst (A)

Neurology Department, CHRU Gui de Chauliac, Montpellier, France (A.T.S., C.A.).

Mirjam R Heldner (MR)

Neurology Department, Inselspital, University Hospital and University of Bern, Switzerland (M.R.H., S.J.).

Davide Strambo (D)

Stroke Center, Neurology Service, Lausanne University Hospital and University of Lausanne (D.S., P.M.).

Nadia Laksiri (N)

Neurology Department, La Timone University Hospital, Marseille, France (N.L.).

Isabelle Girard Buttaz (I)

Neurology Department, Valenciennes Hospital, France (I.G.B.).

Jérémie Papassin (J)

Stroke Unit, Grenoble University Hospital, France (J.P.).
Neurology Department, Chambery Hospital, France (J.P.).

Igor Sibon (I)

Stroke Unit, Bordeaux University Hospital, France (I.S.).

Nicolas Chausson (N)

Neurology Department, Centre Hospitalier du Sud Francilien, Corbeil-Essones, France (N.C., L.B.).

Patrik Michel (P)

Stroke Center, Neurology Service, Lausanne University Hospital and University of Lausanne (D.S., P.M.).

Charlotte Rosso (C)

Sorbonne Université, Institut du Cerveau et de la Moelle Épinière, ICM, Inserm U 1127, CNRS UMR 7225, AP-HP; Urgences Cérébro-Vasculaires; ICM Infrastructure Stroke Network, Hôpital Pitié-Salpêtrière, F-75013, Paris, France (C.R.).

Frédéric Bourdain (F)

Neurology Department, Centre Hospitalier de la Cote Basque, Bayonne, France (F.B.).

Chantal Lamy (C)

Neurology Department, Amiens University Hospital, France (C.L.).

David Weisenburger-Lile (D)

Neurology Department, Foch University Hospital, Suresnes, France (D.W.-L.).

Pierre Agius (P)

Neurology Department, St Nazaire Hospital, France (P.A.).

Marion Yger (M)

Neurology Department, Saint-Antoine Hospital, Paris, France (M.Y.).

Michael Obadia (M)

Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France (N.B., M.O., L.B., P.S.).

Denis Sablot (D)

Neurology Department, Centre Hospitalier de Perpignan, France (D.S.).

Nicolas Legris (N)

Neurology Department, CHU Kremlin Bicêtre, France (N.L.).

Simon Jung (S)

Neurology Department, Inselspital, University Hospital and University of Bern, Switzerland (M.R.H., S.J.).

Sara Pilgram-Pastor (S)

Department of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, Switzerland (S.P.-P.).

Hilde Henon (H)

University of Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, France (H.H.).

Lucy Bernardaud (L)

Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France (N.B., M.O., L.B., P.S.).
Neurology Department, Centre Hospitalier du Sud Francilien, Corbeil-Essones, France (N.C., L.B.).

Caroline Arquizan (C)

Neurology Department, CHRU Gui de Chauliac, Montpellier, France (A.T.S., C.A.).

Jean-Claude Baron (JC)

Neurology Department, GHU Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Université de Paris, INSERM UMR 1266, FHU NeuroVasc, France (N.B., G.T., J.-C.B.).

Pierre Seners (P)

Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France (N.B., M.O., L.B., P.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH